Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism
- PMID: 9916685
Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism
Abstract
A novel cytokine from a thymic stromal cell line (thymic stromal lymphopoietin (TSLP)) promotes the development of B220+/IgM+ immature B cells when added to fetal liver cultures, long term bone marrow cultures, or bone marrow cells plated in semisolid medium. Because the activities of TSLP overlap with those of IL-7 in some in vitro assays, we compared the signaling mechanisms employed by TSLP and IL-7. Proliferation of a factor-dependent pre-B cell line (NAG8/7) in response to either TSLP or IL-7 was inhibited by anti-IL-7R alpha mAbs, suggesting that the functional TSLP receptor complex uses IL-7R alpha. In contrast, three different Abs to the common cytokine receptor gamma-chain had no effect on the response of these cells to TSLP, indicating that the functional TSLP receptor complex does not use the common cytokine receptor gamma-chain. Both cytokines induced activation of Stat5, but only IL-7 induced activation of the Janus family kinases Jak1 and Jak3. In fact, TSLP failed to activate any of the four known Janus family kinases, suggesting that Stat5 phosphorylation is mediated by a novel mechanism. Taken together, these data support the idea that TSLP can make unique contributions to B lymphopoiesis and indicate that it does so by mechanisms distinct from IL-7.
Similar articles
-
Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction.J Immunol. 1999 Dec 1;163(11):5971-7. J Immunol. 1999. PMID: 10570284
-
Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.J Immunol. 2002 Apr 1;168(7):3288-94. doi: 10.4049/jimmunol.168.7.3288. J Immunol. 2002. PMID: 11907084
-
Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19455-60. doi: 10.1073/pnas.1008271107. Epub 2010 Oct 25. Proc Natl Acad Sci U S A. 2010. PMID: 20974963 Free PMC article.
-
Thymic stromal lymphopoietin: master switch for allergic inflammation.J Exp Med. 2006 Feb 20;203(2):269-73. doi: 10.1084/jem.20051745. Epub 2006 Jan 23. J Exp Med. 2006. PMID: 16432252 Free PMC article. Review.
-
Cytokine functions in the formative stages of a lymphocyte's life.Curr Opin Immunol. 2004 Apr;16(2):180-90. doi: 10.1016/j.coi.2004.02.002. Curr Opin Immunol. 2004. PMID: 15023411 Review.
Cited by
-
The biology of thymic stromal lymphopoietin (TSLP).Adv Pharmacol. 2013;66:129-55. doi: 10.1016/B978-0-12-404717-4.00004-4. Adv Pharmacol. 2013. PMID: 23433457 Free PMC article. Review.
-
Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7R alpha mutant mice.J Exp Med. 2007 Mar 19;204(3):619-31. doi: 10.1084/jem.20061871. Epub 2007 Feb 26. J Exp Med. 2007. PMID: 17325202 Free PMC article.
-
IL-17A+GM-CSF+ Neutrophils Are the Major Infiltrating Cells in Interstitial Lung Disease in an Autoimmune Arthritis Model.Front Immunol. 2018 Jul 2;9:1544. doi: 10.3389/fimmu.2018.01544. eCollection 2018. Front Immunol. 2018. PMID: 30013577 Free PMC article.
-
TSLP, IL-33, and IL-25: Not just for allergy and helminth infection.J Allergy Clin Immunol. 2022 Dec;150(6):1302-1313. doi: 10.1016/j.jaci.2022.07.003. Epub 2022 Jul 19. J Allergy Clin Immunol. 2022. PMID: 35863509 Free PMC article. Review.
-
Comparative Efficacy and Safety of Tezepelumab and Other Biologics in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis.Cells. 2022 Feb 26;11(5):819. doi: 10.3390/cells11050819. Cells. 2022. PMID: 35269440 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous